Turner provides building services to clients who value diligence, resourcefulness and creativity. Because Turner is a global company based in North America, we are able to offer clients the accessibility and support of a local firm with the stability and resources of a multi-national organization.
$20.4B Annual Revenue YTD Sept 2025
15,000 Employees
1,500Projects
Turner builds the future with integrity, teamwork, and commitment. We combine local expertise with global reach, supported by our parent company HOCHTIEF and the ACS Group. Since 1902, our culture of hard work and treating clients as “respected friends” has guided every project. As the industry evolves, Turner adapts—embracing innovation, listening to clients, and delivering complex projects with emerging technologies. With 60+ offices globally, Turner completes 1,500 projects annually in markets like healthcare, education, aviation, and data centers. The company continuously improves through Virtual Design and Construction (VDC) and lean practices to maximize value and efficiency.
Pharmaceutical and biotech facilities demand specialized expertise. Turner’s dedicated Pharma & Biotech team brings deep technical and regulatory knowledge to every project. The team includes CQV experts, cGMP compliance and quality professionals, and engineers with advanced degrees who understand the complexities of cleanroom design, high-purity systems, and regulated manufacturing environments.
As active members of ISPE and other leading organizations, our professionals ensure every project aligns with current industry standards and best practices. Supporting all Turner business centers globally, mobilizing wherever needed to guide projects through planning, design, construction, and validation.
With a proven record of success, including ENR’s Lab of the Year and ISPE’s Facility of the Year awards, Turner delivers process-driven construction and validated environments that meet the strictest pharmaceutical and biotech standards—from concept through commissioning.
Top 5
Pharma Builder in US
Consistently ranked by Engineering News-Record
$2.5B
Pharma + Biotech
Completed pharmaceutical / biotech projects In the past three years.
40
Active Pharma + Biotech Projects
In 2026 we have over 40 active BioTech, Pharma and Life Sciences projects. +
1,300+
Pharma + Biotech Projects
Completed in Biotech, Pharma, and Life Sciences projects nationwide.
Pharmaceutical and biotech manufacturing is at the forefront of medical innovation and national progress. Turner’s specialized Pharma & Biotech teams deliver this through integrated expertise in cGMP, CQV (Commissioning, Qualification, and Validation), and global regulatory standards. Our specialists collaborate across disciplines to optimize facility design, process integration, and technical functionality—ensuring every project achieves exceptional precision, quality, and compliance.
Using a modular “kit-of-parts” approach, Turner accelerates time to market while maintaining flexibility and control. As active members of ISPE, PDA, and other leading organizations, our professionals stay aligned with evolving standards to keep clients ahead of regulatory expectations. Turner’s portfolio spans every scale—from R&D pilot plants and ISO Level 1–9 cleanrooms to turnkey manufacturing suites and incubator facilities supporting the next generation of biotech innovation.
cGMP Manufacturing
Bulk Production, Modular Cleanrooms, Pilot Plants, Aseptic Processing, Cold Chain Logistics
Vivarium + Containment Environments
AAALAC-Compliant Suites, BSL-2/3 Labs, Secure Containment, Preclinical Research Spaces
Research & Development
Research Suites, Bioengineering Labs, Pilot-Scale Testing, Clinical Development Environments
Biotech and Cell & Gene Therapy
Biologics, Personalized Medicine, Viral Vector Labs, Modular Biomanufacturing, Aseptic Suites
Incubator + Innovation
Facilities
Flexible Lab Modules, Shared Core Spaces, Startup Accelerators, Collaborative Research Hubs
Turner delivers end-to-end solutions for pharmaceutical, biotech, and life science facilities—managing every phase from concept through Commissioning, Qualification + Validation (CQV) to ensure speed, compliance, and operational excellence.
Facility Planning + Adaptive Reuse
Strategic early-stage planning and adaptive reuse of offices, warehouses, or labs into high-performance cGMP and R&D spaces. Our approach reduces cost, speeds delivery, and extends asset value.
Scope + Feasibility
Validated cost, schedule, and constructability analyses aligned with FDA, EMA, and ISPE standards to define clear, compliant project paths.
Process + Facility Programming
Integration of process, equipment, and spatial needs to optimize flow, scalability, and future production goals.
Design Integration + Scope Control
Collaborative, flexible design management that aligns performance, cost, and constructability through Target Value Design and early trade engagement.
Digital Integration + Data Readiness
Ensuring facilities are Pharma 4.0-ready, with digital twins, validated data environments, and SCADA/MES connectivity for real-time monitoring and paperless CQV.
GMP-Focused Design Review
Comprehensive compliance and risk reviews to ensure full alignment with FDA, EMA, NIH, and ISPE requirements.
Equipment Strategy + Procurement
Independent guidance and early sourcing of longlead systems, modular skids, and specialized cleanroom components through SourceBlue.
Factory Oversight + FAT/SAT
Factory and site testing that verifies performance, accelerates turnover, and ensures validated readiness.
Integrated QA/QC and CQV programs that confirm compliance and deliver inspection-ready facilities at handover.
Safety + Contamination Control
Strict GMP safety and contamination protocols safeguard personnel, product, and operations— achieving zero downtime during live cutovers.
Integrated Team Delivery
Using IPD and Lean principles, Turner unites owners, designers, and builders to streamline decisions and drive schedule certainty.
Facility Lifecycle Support
Post-handover support ensures smooth operations and long-term reliability, keeping every turnkey facility performing at peak efficiency.
Modern pharmaceutical and biotech facilities demand speed, precision, and unity of purpose. Turner’s collaborative delivery model brings owners, designers, engineers, and trade partners together from day one to deliver smarter, faster, and more predictable outcomes.
Turner embraces Integrated Project Delivery and Lean Construction principles to align all stakeholders around shared goals for cost, schedule, and performance. Using Target Value Design and co-located Big Room collaboration, our teams solve problems in real time—reducing redesigns, improving constructability, and accelerating decision-making. Every project benefits from transparent communication, early coordination, and measurable results.
Success in pharma construction depends on precision coordination. Turner engages specialized trade partners early—process piping, cleanroom installation, and automation experts—to integrate design and fabrication workflows. This early alignment allows modular cleanroom systems, process skids, and OEM equipment to be designed for seamless installation and validation, safeguarding quality and compliance from concept through commissioning.
Turner leverages BIM/VDC, Procore, and other real-time platforms to ensure every team member stays aligned on design intent, safety, and schedule. Weekly pull-planning sessions, shared 3D models, and digital QA/QC tracking enable full transparency across disciplines. The result: a unified delivery process built on trust, accountability, and shared success.
Turner prepares facilities for the connected, data-driven future. We integrate digital twins, robotics, and SCADA/MES-ready infrastructure to create smart, responsive environments. Through paperless CQV and automated data validation, clients gain real-time visibility into cleanroom conditions, utilities, and performance—delivering faster commissioning and greater operational insight.
Turner’s leadership in the pharmaceutical and biotech market is built on technical fluency, disciplined execution, and a culture of collaboration. With more than a thousand completed life-sciences projects, we combine proven construction expertise with emerging technologies to deliver compliant, flexible, and efficient facilities that help clients bring therapies to market faster.
Turner’s CQV-first approach ensures every facility is built for rapid, compliant startup. By integrating commissioning specialists early, we align construction activities with qualification milestones, compressing timelines and accelerating time to market.
Our projects apply Quality by Design (QbD) principles from the start—defining critical quality attributes early, embedding QA/QC into every phase, and achieving rightfirst-time startup. This disciplined approach reduces rework, improves documentation accuracy, and ensures readiness for inspection and production on Day One.
Turner’s teams are fluent in FDA, EMA, ISPE, and ISO standards. We deliver globally compliant, audit-ready environments—from sterile cGMP manufacturing suites and ISO Class 1–9 cleanrooms to BSL-2/3 containment labs and vivariums. Every system is built, tested, and documented to meet the strictest regulatory and validation requirements.
Through digital QA/QC tracking, factory acceptance testing, and paperless turnover packages, Turner shortens validation cycles while maintaining full data integrity. Integrated digital twins and automated reporting tools give owners real-time commissioning status and complete traceability—simplifying regulatory reviews and accelerating occupancy.
We help clients repurpose assets while maintaining cGMP integrity. Our integrated methods also support adaptive reuse and sustainability goals. Turner transforms existing assets into compliant research and manufacturing environments—reducing embodied carbon, shortening schedules, and supporting long-term operational efficiency.
0.67
Experience Modification Rate (2025)
Safety and compliance are non-negotiable in regulated pharma environments. Our approach prioritizes pretask risk assessments, trade partner engagement, and contamination prevention protocols from day one.
Active cleanroom renovation with zero impact to operations
On-site medics and mental health counselors to ensure worker wellness American Regent Live campus delivery with highhazard containment coordination Agilent Frederick
Our safety and QA/QC programs are aligned with the life sciences industry’s most rigorous requirements.
• Zoning and containment planning
• Material flow logistics and traceability
• Clean build techniques
• PPE protocols and pharmaceutical jobsite training
• Equipment rigging and FAT/SAT coordination
• GMP-aligned turnover packages
• Real-time digital QA/QC tracking
• BIM-to-field data capture supports paperless CQV and accelerates turnover packages.
Our pre-task planning and commissioning-first mindset ensures that what’s built is ready to validate—efficiently and reliably.
Turner prioritizes safety with decades of experience, expert partnerships, and strict subcontractor vetting. Our approach includes geotech verification, controlled access, and clear communication for secure and successful projects.
Turner’s safety protocols are tailored to the complex needs of pharmaceutical and biotech facilities, where product integrity, personnel protection, and regulatory compliance are critical. Our processes address the unique risks of working in active GMP environments, leveraging collaboration between owners, engineers, and construction teams.
We ensure rigorous subcontractor vetting, utility verification, contamination controls, and clean construction methods. Defined zones for material handling, staging, and equipment access support strict workflow separation. Coordinated planning with OEMs, system integrators, and commissioning teams drives safe, efficient delivery - from excavation to operational readiness.
From bulk production plants to sterile fill-finish suites, Turner delivers cGMP manufacturing environments built for precision, safety, and speed. Each facility is designed to meet global regulatory standards and accelerate time to market— integrating modular cleanroom systems, advanced utilities, and seamless CQV execution.
Project Expertise
• Aseptic Fill-Finish + Sterile Manufacturing
• Bulk Drug Substance + Drug Product Facilities
• Modular Cleanroom Systems (ISO 1–9)
• Process Utilities + High-Purity Piping
• Prefabricated Process Skids + Equipment Integration
• Paperless CQV + Validation Programs
• Compliance with FDA, EMA, ISPE, and EU GMP Standards
Turner builds flexible, high-performance R&D environments that evolve with discovery and innovation. Our laboratories support translational research and pilot-scale development with adaptable infrastructure, advanced MEP systems, and integrated digital controls that enable smarter science.
• Translational Research + Pilot-Scale Labs
• Wet + Dry Research Environments
• Analytical + Quality Control Labs
• Digital Twin + Smart Building Integration
• Modular Labs + Utility Infrastructure
• Collaboration + Knowledge Exchange Zones
• Compliance with NIH, CDC, FDA, and ISPE Guidelines
AstraZeneca P95/Area 6 R&D Laboratory
Gaithersburg, MD
North Carolina Central University, BRITE Biomanufacturing Research Facility Durham, NC
Allergan Research and Development Build-Out Branchburg, NJ
Turner delivers biomanufacturing facilities that advance personalized medicine and next-generation therapeutics. These environments demand precise control, validated containment, and flexible systems that scale with innovation— meeting the highest standards for safety, compliance, and quality.
• Cell + Gene Therapy Production Suites
• Viral Vector + mRNA Manufacturing
• Modular Bioprocessing Cleanrooms (ISO 1–8)
• BSL-2/3 Containment + Process Isolation
• Integrated Automation + SCADA/MES Readiness
• Single-Use Technology + Skid Integration
• Compliance with FDA, EMA, ISPE, and NIH Guidelines
CFD Research Corporation Renovation and Expansion
Genmab Office and Laboratory Renovation
Princeton, NJ
Turner creates incubator and innovation hubs that foster collaboration, discovery, and growth across the life sciences ecosystem. These facilities combine flexible lab modules, adaptive reuse, and shared infrastructure to support startups, academic researchers, and commercial partners driving the next wave of biotech advancement.
Project Expertise
• Flexible Wet/Dry Lab + Office Suites
• Shared Core Facilities + Collaboration Zones
• Adaptive Reuse + Rapid Retrofit Projects
• BSL-2 Research + Pilot Labs
• Modular Labs + Reconfigurable Infrastructure
• Sustainable Building Systems + Smart Operations
• Compliance with NIH, CDC, FDA, and ISPE Guidelines
Turner designs and builds vivariums and high-containment research facilities that ensure safety, precision, and regulatory integrity. With more than 75 completed vivarium projects totaling over 12 million square feet, our experience spans animal research, infectious disease containment, and translational science environments. These complex facilities balance operational efficiency with biosecurity— meeting the stringent requirements of NIH, CDC, ISPE, and AAALAC-accredited programs.
• AAALAC-Compliant Vivariums
• BSL-2 + BSL-3 Research Laboratories
• Controlled Environments + Bioexclusion Systems
• Redundant MEP + Life-Safety Infrastructure
• Specialized Systems: Cage Wash, Bedding, Feed + Waste Neutralization
• Containment Commissioning + Validation
• Modular + Prefabricated Containment Systems
• Compliance with NIH, CDC, AAALAC, AALAS, and ISPE Guidelines
